Paper36944864
Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.
Zhang L and 8 others. Pain Ther, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China. Papers, record 36944864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944864
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34145431 | Diagnosis and management of migraine in ten steps. | Nat Rev Neurol | 2021 | https://conductscience.org/library/papers/34145431 | PubMed |
| 2 | 31699022 | Burden of headache disorders in China, 1990-2017: findings from the Global Burden of Disease Study 2017. | J Headache Pain | 2019 | https://conductscience.org/library/papers/31699022 | PubMed |
| 3 | 32404048 | Migraine treatment and healthcare costs: retrospective analysis of the China Health Insurance Research Association (CHIRA) database. | J Headache Pain | 2020 | https://conductscience.org/library/papers/32404048 | PubMed |
| 4 | 30806518 | Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. | Cephalalgia | 2019 | https://conductscience.org/library/papers/30806518 | PubMed |
| 5 | 29556965 | Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy. | Neurotherapeutics | 2018 | https://conductscience.org/library/papers/29556965 | PubMed |
| 6 | 23879870 | Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. | Headache | 2013 | https://conductscience.org/library/papers/23879870 | PubMed |
| 7 | 31410844 | Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. | Headache | 2019 | https://conductscience.org/library/papers/31410844 | PubMed |
| 8 | 32510611 | A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment. | Headache | 2020 | https://conductscience.org/library/papers/32510611 | PubMed |
| 9 | 32641075 | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme. | BMC Neurol | 2020 | https://conductscience.org/library/papers/32641075 | PubMed |
| 10 | 25773005 | Drug safety in acute migraine treatment. | Expert Opin Drug Saf | 2015 | https://conductscience.org/library/papers/25773005 | PubMed |
| 11 | 12864756 | Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. | Headache | 2003 | https://conductscience.org/library/papers/12864756 | PubMed |
| 12 | 31174999 | Pathophysiology, prevention, and treatment of medication overuse headache. | Lancet Neurol | 2019 | https://conductscience.org/library/papers/31174999 | PubMed |
| 13 | 18826746 | Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand. | Curr Med Res Opin | 2008 | https://conductscience.org/library/papers/18826746 | PubMed |
| 14 | 27531722 | Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. | BMJ Open | 2016 | https://conductscience.org/library/papers/27531722 | PubMed |
| 15 | 27843332 | Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. | Diabetes Metab Syndr Obes | 2016 | https://conductscience.org/library/papers/27843332 | PubMed |
| 16 | 10214536 | Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. | Cephalalgia | 1999 | https://conductscience.org/library/papers/10214536 | PubMed |
| 17 | 11294956 | Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. | Neurology | 2001 | https://conductscience.org/library/papers/11294956 | PubMed |
| 18 | 10146874 | The validity and reproducibility of a work productivity and activity impairment instrument. | Pharmacoeconomics | 1993 | https://conductscience.org/library/papers/10146874 | PubMed |
| 19 | 11966858 | What do patients with migraine want from acute migraine treatment? | Headache | 2002 | https://conductscience.org/library/papers/11966858 | PubMed |
| 20 | 23731663 | Health-care utilization for primary headache disorders in China: a population-based door-to-door survey. | J Headache Pain | 2013 | https://conductscience.org/library/papers/23731663 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41109979 | A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults. | Clin Pharmacol Drug Dev | 2026 | https://conductscience.org/library/papers/41109979 | PubMed |
| 39416954 | Modulating oxidative stress and neurogenic inflammation: the role of topiramate in migraine treatment. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/39416954 | PubMed |
| 39333875 | First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients. | J Headache Pain | 2024 | https://conductscience.org/library/papers/39333875 | PubMed |
| 38627638 | Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial. | J Headache Pain | 2024 | https://conductscience.org/library/papers/38627638 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944864
GET https://conductscience.org/api/papers/v1/36944864/references?page=2